BRVE Buy Disclosure
Forbion Growth Opportunities Fund Iii Cooperatief U.a. · SEC Form 4 · Filed Aug 7, 2026
Buy
Calculated transaction value
$34.56M
Forbion Growth Opportunities Fund Iii Cooperatief U.a. 10% owner
BRVE
Braveheart Bio, Inc.
BRVE
Transaction date
Aug 7, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed same day
BRVE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,920,000 shares @ $18
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-340528
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$64.8M
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Braveheart Bio, Inc. BRVE | Conversion | Aug 7, 2026 | $0 |
| Braveheart Bio, Inc. BRVE | Conversion | Aug 7, 2026 | $0 |
| Braveheart Bio, Inc. BRVE | Conversion | Aug 7, 2026 | $0 |
| Braveheart Bio, Inc. BRVE | Buy | Aug 7, 2026 | $30.24M |
| Braveheart Bio, Inc. BRVE | Conversion | Aug 7, 2026 | $0 |
| Braveheart Bio, Inc. BRVE Current | Buy | Aug 7, 2026 | $34.56M |